Newsroom
Sorted by: Latest
-
Expereo Wins Best Digital Customer Experience in Europe at Telecom Review Excellence Awards
AMSTERDAM--(BUSINESS WIRE)--The Telecom Review Excellence Awards closed the 20th Telecom Review Leaders' Summit, celebrating the companies and industry leaders, both global and regional, that stood out over the past year. Telecom Review Group, together with an independent panel of judges, recognised the strongest performers in corporate growth, technological deployment, ICT investment, customer experience, green initiatives and resilience, as well as individual capabilities and brand contributi...
-
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
GUILFORD, Conn.--(BUSINESS WIRE)--CE mark and UKCA approvals support Swoop system Model 2 expansion as Hyperfine highlights portable MRI in brain health awareness efforts....
-
Familiar Therapeutics Launches with $5 Million Seed to Close the Gap Between Human and Veterinary Medicine
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Familiar Therapeutics launched today with $5 million in seed funding to bring the advances of modern human medicine to dogs and cats. The round was led by Pioneer Fund, Icehouse Ventures and BreakTHRU, a syndicate of animal-health industry leaders and veterinarians, with participation from angel investors. Over the past two decades, a new generation of medicines has changed the outlook for people with chronic and life-threatening diseases. Dogs and cats de...
-
ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the US availability of ZEGFROVY® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, and whose disease has progressed on or after platinum-based chemotherapy.1 The US Food and Drug Administration granted accelerated approval to ZEGFROVY based on res...
-
Navvis Introduces New Solution to Help Health Systems Build the Operating Capabilities Required to Achieve High Performance in CJR-X
ST. LOUIS--(BUSINESS WIRE)--Navvis, the leading value-based care enablement company, today announced a new CJR-X solution built to help health systems achieve high performance in the Centers for Medicare & Medicaid Services (CMS) mandatory and newly finalized Comprehensive Care for Joint Replacement Expanded (CJR-X) model. Joint replacement is one of the most profitable service lines for health systems across the U.S. today, and CJR-X gives health systems a mandatory new way to protect and...
-
MMT Unveils Next-Generation Website to Enhance Customer Experience and Simplify Access to Medical Device and Industrial Manufacturing Solutions
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Medical Manufacturing Technologies (MMT), a leading provider of medical device and industrial manufacturing equipment, automation, and process expertise, today announced the launch of its redesigned website. As the first of its kind in the manufacturing solutions industry, this intuitive digital experience redefines how manufacturers access specialized technical expertise and identify tailored solutions to improve production performance. Reflecting MMT’s...
-
Alliant Private Client Selected as Featured Insurance Industry Expert in Public Television’s “All Access with Andy Garcia”
IRVINE, Calif.--(BUSINESS WIRE)--Alliant Private Client is the featured expert on the risk management needs of wealthy individuals and families for “All Access with Andy Garcia."...
-
SOAR AI Releases Investor Presentation Outlining its Planned Path from the Initial $1.17 Billion of Contracted Orders to a Multi-Site AI Infrastructure Platform
NORTH CANTON, Ohio--(BUSINESS WIRE)--SOAR AI, Inc. (NYSE American: SOAR) (“SOAR AI” or the “Company”), today announced that it has released an updated investor presentation providing an overview of its AI infrastructure business, contracted customer orders, deployment plan and growth strategy. The presentation is available in the Investors section of the Company’s website at ir.soarai.com and has been furnished with the U.S. Securities and Exchange Commission (the “SEC”) in a Current Report on...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 21.10.2026 FJUL.LN IE000YJBT6I5 150,002.00 USD 4,436,535.77 29.577 ...
-
Chemify Appoints Rima Alameddine to Its Board of Directors
GLASGOW, Scotland--(BUSINESS WIRE)--Digital chemistry company Chemify has announced the appointment of Rima Alameddine to its Board of Directors as an independent non-executive director....